Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance

Circulation

Volumn 95, Issue 9, 1997, Pages 2250-2253

  Hare, Joshua M ^a,c   Shernan, Stanton K ^b   Body, Simon C ^b   Graydon, Erin ^b   Colucci, Wilson S ^b   Couper, Gregory S ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

assist device; heart failure; hypertension, pulmonary; vasodilators; ventricles

Indexed keywords

INOTROPIC AGENT; NITRIC OXIDE; NITROGEN DIOXIDE; OXYGEN; VASODILATOR AGENT;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC CIRCULATION; TREATMENT OUTCOME;

EID: 0030892739     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.9.2250     Document Type: Article

References (19)

1. Lunn RJ. Inhaled nitric oxide therapy. Mayo Clin Proc. 1995; 70:247-255.
2. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90:2780-2785.
3. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 1994;24:982-988.
4. Kieler-Jenson N, Rickslen S-E, Stenqvist O, Bergh C-H, Lindelov B, Wennmalm A, Waagstein F, Lundin S. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant. 1994;13: 366-375.
5. Bocchi EA, Bacal F, Auler JOC Jr, Carmone MJDC, Belotti G, Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol. 1994;74:70-72.
6. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the contractile response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
7. Keaney JF Jr, Hare JM, Kelly RA, Loscalzo J, Smith TW, Colucci WS. Inhibition of nitric oxide synthase potentiates the positive inotropic response to β-adrenergic stimulation in normal dogs. Am J Physiol. 1996;271:H2646-2652.
8. Dickstein ML, Burkhoff D. A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant. 1996;15: 715-721.
9. McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ, and the Implantable LVAD Study Group. Implantable left ventricular assist device: approaching an alternative for end-stage heart failure. Circulation. 1994;90(suppl II):II-83-II-86.
10. Frazier OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, Dasse KA. Multicenter clinical evaluation of the Heart-mate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080-1090.
11. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation. 1993;88:2884-2887.
12. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 1992;89:7674-7677.
13. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitroso-haemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221-226.
14. Szwarc RS, Graves CL, Flemming F, Ball HA, Bryan CA, Bohn D, Benson LN. Evidence for systemic effects of inhaled nitric oxide in the anesthetized minipig. Circulation. 1995;92(suppl I):I-701. Abstract.
15. Troncy E, Vinay P, Francoeur M, Salazkin I, Biaise G. Nitric oxide by inhalation influences renal function in pigs. Endothelium. 1995;3(suppl):S-114. Abstract.
16. Polidori D, DiPierro F, Lankford E, Doering E, Hanson W, Acker M, Loh E. Cardiovascular effects of nitric oxide in a canine model of cardiomyopathy. Circulation. 1995;92(suppl I):I-184. Abstract.
17. Hayward C, Kalnins W, Rogers P, Feneley M, Macdonald P, Kelly R. Evaluation of the effects of inhaled nitric oxide on normal human left ventricular function. Circulation. 1995;92(suppl I):I-79l. Abstract.
18. Schwinger RHG, Bohm M, Koch A, Schmidt U, Morano I, Eissner HJ, Uberfuhr P, Reichart B, Erdmann E. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res. 1994;74:959-969.
19. Page RD, Harringer W, Hodakowski GT, Guerrero JL, LaRaia PJ, Austen WG, Vlahakes GJ. Determinants of maximal right ventricular function. J Heart Lung Transplant. 1992;11:90-98.